Dexamethasone attenuates kainate-induced AP-1 activation in rat brain

Tino Unlap, Richard S Jope

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The goal of this investigation was to determine if administration of the synthetic glucocorticoid dexamethasone modulates rat brain AP-1 DNA binding activity. Treatment with the selective excitatory amino acid agonist kainate was used to activate AP-1 formation. Kainate (12 mg/kg) administration induced a biphasic activation of AP-1 in rat cerebral cortex and hippocampus with maximal levels observed at 1.5 h and 4.5 h and lower levels at 3 h and 6 h. Kainate also induced biphasic increases in the concentrations of some of the AP-1 constituent proteins (immediate early gene protein products), with initial increases of c-Jun, Fos, and Jun B occurring at 1.5 h and secondary larger increases at 4.5 h, but the level of Jun D was not altered by kainate treatment. Pretreatment with dexamethasone (1 mg/kg) reduced AP-1 activity at both 1.5 h and 4.5 h after kainate administration in both brain regions. Dexamethasone pretreatment did not modify the concentrations of the AP-1 constituent proteins obtained after kainate administration except for a reduction of Jun B levels 1.5 h after kainate. These results demonstrate that elevated glucocorticoid levels reduce the stimulation by kainate of AP-1 activity in rat cortex and hippocampus without causing corresponding decreases in the levels of immediate early gene proteins. Binding of the activated glucocorticoid receptor to c-Jun or Fos is likely to contribute to the decreased AP-1 DNA binding activity following dexamethasone treatment.

Original languageEnglish
Pages (from-to)275-282
Number of pages8
JournalMolecular Brain Research
Volume24
Issue number1-4
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Kainic Acid
Transcription Factor AP-1
Dexamethasone
Brain
Immediate-Early Proteins
Immediate-Early Genes
Glucocorticoids
Hippocampus
Proteins
Excitatory Amino Acid Agonists
DNA
Glucocorticoid Receptors
Cerebral Cortex

Keywords

  • AP-1
  • Dexamethasone
  • Fos
  • Glucocorticoid
  • Immediate early gene
  • Jun

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. / Unlap, Tino; Jope, Richard S.

In: Molecular Brain Research, Vol. 24, No. 1-4, 01.01.1994, p. 275-282.

Research output: Contribution to journalArticle

@article{922055a84804413a84d66db1eb31975f,
title = "Dexamethasone attenuates kainate-induced AP-1 activation in rat brain",
abstract = "The goal of this investigation was to determine if administration of the synthetic glucocorticoid dexamethasone modulates rat brain AP-1 DNA binding activity. Treatment with the selective excitatory amino acid agonist kainate was used to activate AP-1 formation. Kainate (12 mg/kg) administration induced a biphasic activation of AP-1 in rat cerebral cortex and hippocampus with maximal levels observed at 1.5 h and 4.5 h and lower levels at 3 h and 6 h. Kainate also induced biphasic increases in the concentrations of some of the AP-1 constituent proteins (immediate early gene protein products), with initial increases of c-Jun, Fos, and Jun B occurring at 1.5 h and secondary larger increases at 4.5 h, but the level of Jun D was not altered by kainate treatment. Pretreatment with dexamethasone (1 mg/kg) reduced AP-1 activity at both 1.5 h and 4.5 h after kainate administration in both brain regions. Dexamethasone pretreatment did not modify the concentrations of the AP-1 constituent proteins obtained after kainate administration except for a reduction of Jun B levels 1.5 h after kainate. These results demonstrate that elevated glucocorticoid levels reduce the stimulation by kainate of AP-1 activity in rat cortex and hippocampus without causing corresponding decreases in the levels of immediate early gene proteins. Binding of the activated glucocorticoid receptor to c-Jun or Fos is likely to contribute to the decreased AP-1 DNA binding activity following dexamethasone treatment.",
keywords = "AP-1, Dexamethasone, Fos, Glucocorticoid, Immediate early gene, Jun",
author = "Tino Unlap and Jope, {Richard S}",
year = "1994",
month = "1",
day = "1",
doi = "10.1016/0169-328X(94)90140-6",
language = "English",
volume = "24",
pages = "275--282",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-4",

}

TY - JOUR

T1 - Dexamethasone attenuates kainate-induced AP-1 activation in rat brain

AU - Unlap, Tino

AU - Jope, Richard S

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The goal of this investigation was to determine if administration of the synthetic glucocorticoid dexamethasone modulates rat brain AP-1 DNA binding activity. Treatment with the selective excitatory amino acid agonist kainate was used to activate AP-1 formation. Kainate (12 mg/kg) administration induced a biphasic activation of AP-1 in rat cerebral cortex and hippocampus with maximal levels observed at 1.5 h and 4.5 h and lower levels at 3 h and 6 h. Kainate also induced biphasic increases in the concentrations of some of the AP-1 constituent proteins (immediate early gene protein products), with initial increases of c-Jun, Fos, and Jun B occurring at 1.5 h and secondary larger increases at 4.5 h, but the level of Jun D was not altered by kainate treatment. Pretreatment with dexamethasone (1 mg/kg) reduced AP-1 activity at both 1.5 h and 4.5 h after kainate administration in both brain regions. Dexamethasone pretreatment did not modify the concentrations of the AP-1 constituent proteins obtained after kainate administration except for a reduction of Jun B levels 1.5 h after kainate. These results demonstrate that elevated glucocorticoid levels reduce the stimulation by kainate of AP-1 activity in rat cortex and hippocampus without causing corresponding decreases in the levels of immediate early gene proteins. Binding of the activated glucocorticoid receptor to c-Jun or Fos is likely to contribute to the decreased AP-1 DNA binding activity following dexamethasone treatment.

AB - The goal of this investigation was to determine if administration of the synthetic glucocorticoid dexamethasone modulates rat brain AP-1 DNA binding activity. Treatment with the selective excitatory amino acid agonist kainate was used to activate AP-1 formation. Kainate (12 mg/kg) administration induced a biphasic activation of AP-1 in rat cerebral cortex and hippocampus with maximal levels observed at 1.5 h and 4.5 h and lower levels at 3 h and 6 h. Kainate also induced biphasic increases in the concentrations of some of the AP-1 constituent proteins (immediate early gene protein products), with initial increases of c-Jun, Fos, and Jun B occurring at 1.5 h and secondary larger increases at 4.5 h, but the level of Jun D was not altered by kainate treatment. Pretreatment with dexamethasone (1 mg/kg) reduced AP-1 activity at both 1.5 h and 4.5 h after kainate administration in both brain regions. Dexamethasone pretreatment did not modify the concentrations of the AP-1 constituent proteins obtained after kainate administration except for a reduction of Jun B levels 1.5 h after kainate. These results demonstrate that elevated glucocorticoid levels reduce the stimulation by kainate of AP-1 activity in rat cortex and hippocampus without causing corresponding decreases in the levels of immediate early gene proteins. Binding of the activated glucocorticoid receptor to c-Jun or Fos is likely to contribute to the decreased AP-1 DNA binding activity following dexamethasone treatment.

KW - AP-1

KW - Dexamethasone

KW - Fos

KW - Glucocorticoid

KW - Immediate early gene

KW - Jun

UR - http://www.scopus.com/inward/record.url?scp=0028236164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028236164&partnerID=8YFLogxK

U2 - 10.1016/0169-328X(94)90140-6

DO - 10.1016/0169-328X(94)90140-6

M3 - Article

VL - 24

SP - 275

EP - 282

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-4

ER -